Characteristics | Content Agreement, 1–5 Scale* | Content Disagreement, Who Disagree | Effect, Rating as High Effect | Top Pick, Ranking as Top 5 |
---|---|---|---|---|
ANA test | 4.51 ± 0.89 | 11 (6.8) | 121 (77.1) | 131 (84.0) |
HLA-B27 test | 4.55 ± 0.70 | 4 (2.5) | 107 (70.4) | 113 (73.8) |
BMD every 2 years | 4.46 ± 0.84 | 6 (3.8) | 114 (76.0) | 105 (69.5) |
Bisphosphonates for low-risk patients | 4.09 ± 0.89 | 8 (5.1) | 100 (68.0) | 71 (48.0) |
Bone scan to assess for arthritis | 3.99 ± 1.04 | 17 (11) | 74 (50.0) | 64 (43.2) |
↵* Content agreement (anchored 1 = strongly disagree, 2 = somewhat disagree, 3 = neither disagree nor agree, 4 = somewhat agree, 5 = strongly agree). CRA: Canadian Rheumatology Association; ANA: antinuclear antibody; BMD: bone mineral density.